Bangkok: MEDEZE has successfully complied with the Royal Gazette announcement, becoming the first cell bank in Thailand to meet the new standards, thus reinforcing its leadership in advanced medical technology.
According to Thai News Agency, Mediz Group has achieved certification as the first cell bank in Thailand in line with the Department of Medical Sciences' regulations. Dr. Veerapol Khemrangsan, Chief Executive Officer of Medize Group Public Company Limited (MEDEZE), stated that the certification adheres to legal regulations published in the Royal Gazette on October 9, 2025. This underscores the company's commitment to advancing stem cell technology to meet the highest international standards and future medical needs.
The technologies for preserving and accessing stored cells in cell banks are rapidly evolving in Thailand. The scope of cell use for medical, public health purposes, and health innovation research is expanding. To ensure the quality, safety, and efficacy of stored cells, cell bank operations must adhere to international standards. Regulations are necessary to establish criteria and conditions for certifying cell banks to promote and support domestic operations that meet these standards and to prevent unfair business practices.
MEDEZE stands as the only legally licensed and certified stem cell bank in Thailand, offering comprehensive services in stem cell and immune cell banking. With its vast experience and expertise, MEDEZE has emerged as a leading provider of personalized stem cell banking services in Southeast Asia.
For those seeking trustworthy stem cell banking, MEDEZE offers a reliable solution. With international standards ISO 9001:2015 and AABB certification, along with proven technologies like the AXP AutoXpress® Platform and Cryopreservation, MEDEZE ensures accuracy and safety in cell separation and storage. It provides a diverse range of stem cell resources, including umbilical cord blood, tissue, fat, hair follicles, and NK cells, to support various long-term health care plans.